Abstract:SESSION TITLE: Asthma III SESSION TYPE: Original Investigation Poster PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM PURPOSE: Asthmatic inflammation is dominated either by eosinophil or neutrophil accumulation in airways. Resolution of these inflammatory cells is the key to disease alleviation. It is well accepted that eosinophilic airway inflammation is responsive to corticosteroid treatment, while neutrophilic inflammation contributes to most of the corticosteroid-insensitive severe asthma and increases the burden of global health care. Here, we explored a new strategy of effective treatment against corticosteroid-insensitive neutrophilic asthma by small molecule inhibitors against anti-apoptotic protein Bcl-2. METHODS: Expression of Bcl-2 on inflammatory cells and inflamed tissues were detected. Resolution of airway inflammation in allergen-challenged Bcl-2 transgenic mice was analyzed. Mouse eosinophils and neutrophils from bronchoalveolar lavage (BAL) fluid in response to ABT-737 was detected by flow cytometry. Eosinophilic and neutrophilic airway inflammation model were treated with ABT-737 or ABT-199, the apoptosis of inflammatory cells and cytokines level were analyzed and airway hyperresponsiveness to aerosolized methacholine was measured. RESULTS: Significantly higher viability and prolonged lifespan of eosinophils and neutrophils were observed in BAL fluid from allergen-induced airway inflammation mouse model showed. This was probably due to elevated expression levels of Bcl-2 protein in these inflammatory cells. It was striking that inflammatory response induced by allergen dramatically aggravated and persisted in vav-Bcl-2 transgenic mice, where nucleated hematopoietic cells were resistant to apoptosis. Based on these above observations, Bcl-2 inhibitors, ABT-737 or ABT-199, were shown to play efficient roles in alleviation of either eosinophilic or neutrophilic allergen-induced airway inflammation. CONCLUSIONS: ABT-737 or ABT-199 may be promising drugs for the treatment against airway inflammation, especially corticosteroid-insensitive neutrophilic airway inflammation. CLINICAL IMPLICATIONS: It is well-accepted that eosinophilic airway inflammation is responsive to corticosteroid treatment, while neutrophilic inflammation contributes to most of the corticosteroid-insensitive severe asthma. We have provided a new strategy to inhibit allergic airway inflammation, especially the neutrophil-dominated and corticosteroid insensitive airway inflammation, by promoting the death of inflammatory cell with the antagonist of anti-apoptotic proteins Bcl-2 termed ABT-737 or ABT-199. DISCLOSURE: The following authors have nothing to disclose: Bao-ping Tian, Li-xia Xia, Zhengqiang Bao, Wen Li, Zhihua Chen, Songmin Ying, Huahao Shen No Product/Research Disclosure Information

Chemical Chaperones Reverses Autophagic Dysfunction Resulting From Bronchial Asthma in the Lung Tissues of OVA-OVA Mice via Modulating NF-κB Activation

Altered Frequency of NK Cells and Treg Cells by <i>Astragalus</i> Polysaccharide Combined with Budesonide in Asthma Model Mice

Chemical chaperones mitigate experimental asthma by attenuating endoplasmic reticulum stress

Effects of Ozone Repeated Short Exposures on the Airway/lung Inflammation, Airway Hyperresponsiveness and Mucus Production in a Mouse Model of Ovalbumin-Induced Asthma.

The effects of neutralizing anti-murine interleukin-17A monoclonal antibody on ozone-induced inflammation and glucocorticoids insensitivity in a murine model of asthma

Chemical chaperone 4-PBA mitigates TNF alpha mediated ER stress in hASM cells

Carbocistein improves airway remodeling in asthmatic mice

Chalcone-derivative L6H21 attenuates the OVA-induced asthma by targeting MD2

The Effects of Chrysophanol on Ovalbumin (Ova)-Induced Chronic Lung Toxicology by Inhibiting Th17 Response

Study effect of probiotics and prebiotics on treatment of OVA-LPS-induced of allergic asthma inflammation and pneumonia by regulating the TLR4/NF-kB signaling pathway

Chemical Chaperone 4-PBA Mitigates Tumor Necrosis Factor Alpha-Induced Endoplasmic Reticulum Stress in Human Airway Smooth Muscle

α1-Antitrypsin alleviates inflammation and oxidative stress by suppressing autophagy in asthma

Induction of Granulocyte Apoptosis by Bcl-2 Inhibitors Reduces Steroid-Insensitive Airway Inflammation

Mycobacterium vaccae attenuates airway inflammation by inhibiting autophagy and activating PI3K/Akt signaling pathway in OVA-induced allergic airway inflammation mouse model

Intranasal Administration of IL-27 Pre-OVA Sensitization Alleviate Allergic Airway Inflammation in Mice Model

Vitamin D has an effect on airway inflammation and Th17/Treg balance in asthmatic mice

A retro-inverso modified peptide alleviated ovalbumin-induced asthma model by affecting glycerophospholipid and purine metabolism of immune cells

Rapamycin Protects Ova Induced Asthma In Mice Through Regulating Autophagy

Acupoint Catgut-Embedding Therapy Inhibits NF-κB/COX-2 Pathway in an Ovalbumin-Induced Mouse Model of Allergic Asthma.

Acupoint Catgut-Embedding Therapy Inhibits NF- κ B/COX-2 Pathway in an Ovalbumin-Induced Mouse Model of Allergic Asthma

Blockade of NLRP3/Caspase-1/IL-1β Regulated Th17/Treg Immune Imbalance and Attenuated the Neutrophilic Airway Inflammation in an Ovalbumin-Induced Murine Model of Asthma